| Juvenile spondyloarthritis treatment recommendations. | |
| | |
MedLine Citation:
|
PMID: 22543540 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
No specific recommendations for the treatment of juvenile spondyloarthritis have been established. Important differences exist in how spondyloarthritis begins and progresses in children and adults, supporting the need for pediatric-specific recommendations. Recently published recommendations for the treatment of juvenile arthritis consider children with sacroiliitis in a separate group and allow for more accelerated institution of a tumor necrosis factor inhibitor depending on disease activity and prognostic factors that derive primarily from studies of other forms of juvenile arthritis. There is a need to develop measures of disease activity and prognosis specific for juvenile spondyloarthritis that reflect spinal disease, as well as other major clinical features, such as enthesitis, before significant progress can be made in this area. |
| | |
Authors:
|
Shirley M L Tse; Ruben Burgos-Vargas; Robert A Colbert |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The American journal of the medical sciences Volume: 343 ISSN: 1538-2990 ISO Abbreviation: Am. J. Med. Sci. Publication Date: 2012 May |
Date Detail:
|
Created Date: 2012-04-30 Completed Date: 2012-06-26 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 0370506 Medline TA: Am J Med Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 367-70 Citation Subset: AIM; IM |
Affiliation:
|
Hospital for Sick Children, University of Toronto, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arthritis, Juvenile Rheumatoid
/
therapy Child Humans Practice Guidelines as Topic Spondylarthritis / drug therapy* |
| Grant Support | |
ID/Acronym/Agency:
|
ZIA AR041184-02/AR/NIAMS NIH HHS |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Management of comorbidities in ankylosing spondylitis.
Next Document: Economic considerations of the treatment of ankylosing spondylitis.